Literature DB >> 25456376

Does cilengitide deserve another chance?

Marco Tucci1, Stefania Stucci2, Franco Silvestris2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25456376     DOI： 10.1016/S1470-2045(14)70462-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  11 in total

1.  Dissecting and rebuilding the glioblastoma microenvironment with engineered materials.

Authors:  Kayla J Wolf; Joseph Chen; Jason Coombes; Manish K Aghi; Sanjay Kumar
Journal:  Nat Rev Mater       Date:  2019-08-16       Impact factor: 66.308

2.  Inhibition of angiogenesis and tumor progression of MK-0429, an integrin αvβ3 antagonist, on oral squamous cell carcinoma.

Authors:  Takayuki Nakagawa; Kouji Ohta; Takako Naruse; Miyuki Sakuma; Syohei Fukada; Nao Yamakado; Misaki Akagi; Kazuki Sasaki; Chieko Niwata; Shigehiro Ono; Tomonao Aikawa
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-17       Impact factor: 4.322

3.  An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival.

Authors:  Francesco Mannavola; Mario Mandala; Annalisa Todisco; Vanna Chiarion Sileni; Marco Palla; Alessandro Marco Minisini; Laura Pala; Francesca Morgese; Lorenza Di Guardo; Luigia Stefania Stucci; Michele Guida; Alice Indini; Pietro Quaglino; Virginia Ferraresi; Riccardo Marconcini; Maria Chiara Tronconi; Ernesto Rossi; Olga Nigro; Marcella Occelli; Alessio Cortellini; Silvia Quadrini; Giuseppe Palmieri; Jacopo Pigozzo; Paolo Antonio Ascierto; Maria Grazia Vitale; Sabino Strippoli; Pier Francesco Ferrucci; Rossana Berardi; Giovanni Randon; Pietro Cardone; Giovanni Schinzari; Franco Silvestris; Marco Tucci
Journal:  Front Oncol       Date:  2020-09-15       Impact factor: 6.244

4.  The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis : Cilengitide and Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Jeffrey D Ritzenthaler; Michael Zhang; Edilson Torres-Gonzalez; Jesse Roman
Journal:  Lung       Date:  2020-11-04       Impact factor: 2.584

Review 5.  Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy.

Authors:  Aleksandra Ellert-Miklaszewska; Katarzyna Poleszak; Maria Pasierbinska; Bozena Kaminska
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

6.  Disrupting tumor onset and growth via selective cell tagging (SeCT) therapy.

Authors:  Kenward Vong; Tsuyoshi Tahara; Sayaka Urano; Igor Nasibullin; Kazuki Tsubokura; Yoichi Nakao; Almira Kurbangalieva; Hirotaka Onoe; Yasuyoshi Watanabe; Katsunori Tanaka
Journal:  Sci Adv       Date:  2021-04-23       Impact factor: 14.136

7.  A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies.

Authors:  Geert A Cirkel; Bojana Milojkovic Kerklaan; Frédéric Vanhoutte; Annegret Van der Aa; Giocondo Lorenzon; Florence Namour; Philippe Pujuguet; Sophie Darquenne; Filip Y F de Vos; Tom J Snijders; Emile E Voest; Jan H M Schellens; Martijn P Lolkema
Journal:  Invest New Drugs       Date:  2016-01-20       Impact factor: 3.850

8.  The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines.

Authors:  Weiwei Cheng; Fang Feng; Chao Ma; Hui Wang
Journal:  Onco Targets Ther       Date:  2016-03-11       Impact factor: 4.147

Review 9.  Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.

Authors:  Laure Malric; Sylvie Monferran; Julia Gilhodes; Sabrina Boyrie; Perrine Dahan; Nicolas Skuli; Julie Sesen; Thomas Filleron; Aline Kowalski-Chauvel; Elizabeth Cohen-Jonathan Moyal; Christine Toulas; Anthony Lemarié
Journal:  Oncotarget       Date:  2017-08-21

10.  Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin.

Authors:  Saidu Sani; Nikita Pallaoro; Mélissa Messe; Chloé Bernhard; Nelly Etienne-Selloum; Horst Kessler; Luciana Marinelli; Natacha Entz-Werle; Sophie Foppolo; Sophie Martin; Damien Reita; Monique Dontenwill
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.